Reported Jun 5, 2013 · Terminated
Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400…
Aurobindo Pharma USA Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aurobindo Pharma USA Inc · 666 Plainsboro Rd. Suite 210 · Plainsboro, NJ · 08536-3004
Is this the product you have?
- Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets
- NDC 65862-041-01 Manufactured forAurobindo Pharma USA Inc. 2400 Route 130 North, Dayton
- NJ 08810 Manufactured byAurobindo Pharma Limited Hyderabad- 500 072 India
- Lot codes and dates
- Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
- Amount recalled
- 1776 bottles
Where it was sold
- Nationwide
Why it was recalled
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aurobindo Pharma USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.